Investment
Features
FeesSafety
Academy
More
Pluang+

StealthGas offers strong asset-backed value but faces challenges in shareholder returns and governance.

Analyst Insights
18 Sep 2026
Seeking Alpha
View Source
Neutral
StealthGas offers strong asset-backed value but faces challenges in shareholder returns and governance.

StealthGas is one of the cheapest shipping stocks based on price to net asset value, supported by a solid balance sheet and significant asset backing. Despite this, the stock remains undervalued due to weak historical shareholder returns, governance concerns, and uncertainty about future capital allocation. The company has improved its financial position by reducing debt and shrinking its fleet, which strengthens its balance sheet. For the stock to be re-rated higher, StealthGas needs to demonstrate better shareholder returns, with several potential paths to achieve this.

StealthGas is the subject of this update, with Pluang's Industrials sector data providing context as of Sep 18, 2026 17:51 WIB: out of 83 priced US Industrials stocks, 57 rose and 23 fell today. Notable movers include TECK at USD 66.08 with a 1.32% increase, FCEL at USD 17.94 with a 1.30% rise, and SPCE at USD 3.15 up 1.29%. The most notable figure is the 57 stocks that advanced in price.

More News

Duke Energy's stock shows 8.26% upside with strong earnings forecast and mixed institutional interest.

Duke Energy's stock shows 8.26% upside with strong earnings forecast and mixed institutional interest.

Duke Energy Corporation's stock is projected to rise about 8.26% to a price target of $127, down slightly from $133, reflecting confidence despite a recent price dip. The company expects a 4.42% increase in earnings per share to $1.89 and a 3.86% ris...

Analyst Insights
Bullish
2 hours ago
Xenon Pharmaceuticals stock plunges 27.6% after pausing clinical trials due to safety concerns.

Xenon Pharmaceuticals stock plunges 27.6% after pausing clinical trials due to safety concerns.

Xenon Pharmaceuticals halted new patient enrollment in its psychiatry clinical trials for the drug azetukalner after reports of neuropsychiatric side effects. This pause led to a sharp 27.6% drop in its stock price, marking its worst day since 2017. ...

Market News
Bearish
3 hours ago
Innate Pharma beats EPS estimates and secures $75M deal with Sobi, boosting cash runway to 2028

Innate Pharma beats EPS estimates and secures $75M deal with Sobi, boosting cash runway to 2028

Innate Pharma reported an EPS of -$0.24, beating analyst estimates of -$0.29, and revenue of $6.5 million, slightly above expectations. The company secured a strategic partnership with Sobi for its drug lacutamab, receiving a $75 million upfront paym...

Company Fundamentals
Bullish
3 hours ago
HYPE token hits new all-time high after Hyperliquid enables manual USDC/USDT borrowing with HYPE and Bitcoin collateral.

HYPE token hits new all-time high after Hyperliquid enables manual USDC/USDT borrowing with HYPE and Bitcoin collateral.

HYPE token surged 10.5% to $91.20, reaching a new all-time high of $92.56 after Hyperliquid launched manual borrowing of USDC and USDT using HYPE and Bitcoin as collateral. The platform offers a 65% loan-to-value ratio for HYPE, higher than Bitcoin's...

Market News
Bullish
4 hours ago
CleanTech hires Mercator for independent report on fluorspar project in Kentucky, advancing critical mineral exploration.

CleanTech hires Mercator for independent report on fluorspar project in Kentucky, advancing critical mineral exploration.

CleanTech Vanadium Mining Corp. has engaged Mercator Geological Services to prepare an independent technical report on its Campbell-Crotser fluorspar project in Kentucky, following National Instrument 43-101 standards. The report will detail geology,...

Company Fundamentals
Bullish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App